A Significant Courtroom Win for Louisiana Families

A Louisiana judge has delivered a decisive ruling that protects asbestos victims from invasive and speculative defense tactics.

In February 2026, a judge in East Baton Rouge Parish denied a corporate defendant’s request to force genetic testing on a woman suffering from asbestos-related lung cancer, ruling that the company failed to provide sufficient medical evidence to justify such a procedure.

The case involves a Louisiana family alleging injuries caused by asbestos exposure spanning decades. The defendant attempted to shift blame away from asbestos exposure by arguing that the plaintiff’s cancer may have been caused by genetics rather than toxic exposure.

The court rejected that argument—clearly and unequivocally.

Landry & Swarr represented the plaintiffs, successfully opposing not only the genetic testing request, but also additional defense motions aimed at delaying and weakening the case.

What the Court Decided — In Plain English

The defendant asked the court to compel the plaintiff to submit to blood-based genetic testing, claiming her lung cancer might be hereditary.

The judge said no.

Here’s why the ruling matters:

  • The defense failed to present credible medical literature showing that the proposed genetic mutations would independently cause lung cancer.
  • The defense expert was not a licensed medical doctor, and therefore could not legally testify about specific medical causation.
  • The request was based on hypotheticals, not established science.
  • The court was not at a stage where it could justify ordering an invasive medical procedure.

As the judge noted, something had to have precipitated the cancer in a non-smoker diagnosed in her 50s—and speculation was not enough to override patient rights.

The court denied all three defense motions.

The Bigger Issue: Genetics as a Defense Strategy

This ruling is about more than one case.

Across the country, corporations facing asbestos and toxic exposure lawsuits have begun advancing a troubling strategy:

If they can’t deny exposure, they try to blame DNA.

Instead of confronting decades of asbestos use, defendants argue that cancer victims are genetically predisposed—and therefore not entitled to accountability.

This approach raises serious concerns:

  • Privacy: Genetic testing is deeply personal and irreversible.
  • Fairness: A genetic marker does not negate toxic exposure.
  • Science: Many cancers involve complex interactions between environment and genetics—not one or the other.

Louisiana courts are now drawing a line.

This ruling makes clear that defendants cannot force genetic testing without strong medical proof, qualified medical testimony, and a legitimate causal foundation.

Why This Matters for Louisiana Workers and Families

Louisiana has a long industrial history. Many workers were exposed to asbestos decades ago—often unknowingly.

By the time illness appears:

  • Records are incomplete
  • Employers have changed
  • Insurers deny responsibility
  • And now, defendants attempt to shift blame to genetics

This ruling protects families from being put on the defensive for their own biology.

It reinforces a simple principle:

If exposure caused harm, accountability cannot be avoided by speculation.

Standing Firm in the Courtroom

Landry & Swarr has spent decades standing up for Louisiana families harmed by asbestos exposure.

This ruling reflects what happens when defense tactics are challenged with preparation, science, and a deep understanding of how these cases are fought.

When companies attempt to rewrite the rules, the courtroom matters.

And so does who’s standing beside you.